MedTrace Logo

Multidisciplinary Digital Therapeutics of Patellofemoral Pain Syndrome Versus Usual Care

NCT05614583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-07-31

No results posted yet for this study

Summary

This randomized controlled pilot study will be evaluating an app, MORT-PFPS app (ETH-01K), owned by EverEx, Inc., to examine safety and effectiveness in individuals with patellofemoral pain syndrome.

Conditions

  • Patellofemoral Pain Syndrome

Interventions

DEVICE

MORT-PFPS app

The MORT-PFPS, developed by EverEx, Inc., is designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.

OTHER

treatment as usual (TAU)

In the control group, psychoeducation is delivered and self-exercise is recommended.

Sponsors & Collaborators

  • EverEx Inc.

    lead INDUSTRY

Principal Investigators

  • Chong Bum Chang, Dr. · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2023-10-19
Completion
2023-10-19

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05614583 on ClinicalTrials.gov